INTENDED FOR UK HEALTHCARE PROFESSIONALS

Trimbow – a logical choice of maintenance treatment to help prevent exacerbations in COPD1

Trimbow is indicated for maintenance treatment in adult patients with moderate to severe COPD who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting β2-agonist (for effects on symptoms control and prevention of exacerbations see section 5.1 of the SPC)

Trimbow is a 3-in-1 pMDI that delivers ICS+LABA+LAMA

Each dose contains three established compounds for the treatment of COPD:

ICS: inhaled corticosteroid; LABA: long-acting β2-adrenoceptor agonist; LAMA: long-acting muscarinic antagonist.

Reference:
1.
Trimbow Summary of Product Characteristics, Chiesi Limited. Available at: www.medicines.org.uk/emc/product/761